Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

Details for Australian Patent Application No. 2006203435 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Agrawal, Sudhir; Yu, Dong; Kandimalla, Ekambar R; Zhao, Quiyan

Agent Freehills

Pub. Number AU-B-2006203435

Parent 2001294750

Filing date 9 August 2006

Wipo publication date 31 August 2006

Acceptance publication date 15 May 2008

International Classifications

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

24 August 2006 Complete Application Filed

31 August 2006 Application Open to Public Inspection

  Published as AU-B-2006203435

15 May 2008 Application Accepted

  Published as AU-B-2006203435

11 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203436-Human papilloma virus treatment

2006203434-A process for isolating and purifying viruses, soluble proteins and peptides from plant sources